Cibc World Market Inc. Takes $4.98 Million Position in Centene Corporation $CNC

Posted by Brian Himes on Aug 26th, 2026

Cibc World Market Inc. purchased a new position in Centene Corporation (NYSE:CNC – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 77,519 shares of the company’s stock, valued at approximately $4,976,000.

Several other large investors have also made changes to their positions in CNC. MidFirst Bank purchased a new position in Centene in the 2nd quarter valued at about $32,000. DV Equities LLC purchased a new stake in Centene during the 4th quarter worth approximately $26,000. Elevation Wealth Partners LLC raised its holdings in shares of Centene by 564.6% during the second quarter. Elevation Wealth Partners LLC now owns 658 shares of the company’s stock valued at $42,000 after acquiring an additional 559 shares during the last quarter. IFC & Insurance Marketing Inc. purchased a new position in shares of Centene in the fourth quarter valued at approximately $28,000. Finally, SBI Securities Co. Ltd. increased its position in shares of Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after purchasing an additional 406 shares in the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.

Centene Trading Down 1.1%

NYSE CNC opened at $64.92 on Wednesday. Centene Corporation has a 12 month low of $28.24 and a 12 month high of $69.36. The stock has a market capitalization of $32.07 billion, a P/E ratio of -6.22, a PEG ratio of 0.35 and a beta of 1.08. The firm’s 50-day moving average is $65.08 and its two-hundred day moving average is $52.80. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15.

Centene (NYSE:CNC – Get Free Report) last issued its quarterly earnings data on Monday, July 27th. The company reported $2.51 EPS for the quarter, topping the consensus estimate of $1.09 by $1.42. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The firm had revenue of $53.58 billion for the quarter, compared to analyst estimates of $47.64 billion. During the same period in the prior year, the business posted ($0.16) EPS. The business’s revenue for the quarter was up 9.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current year.

Insider Activity

In related news, General Counsel Christopher Koster sold 47,603 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $65.36, for a total transaction of $3,111,332.08. Following the transaction, the general counsel owned 305,354 shares of the company’s stock, valued at approximately $19,957,937.44. This represents a 13.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CNC shares. Truist Financial boosted their target price on Centene from $71.00 to $78.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Barclays reaffirmed an “overweight” rating and issued a $80.00 target price (up from $75.00) on shares of Centene in a research note on Wednesday, July 29th. Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a report on Friday, July 17th. Robert W. Baird lifted their target price on shares of Centene from $46.00 to $66.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Finally, Wells Fargo & Company set a $69.00 price target on shares of Centene and gave the stock an “equal weight” rating in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Centene presently has a consensus rating of “Hold” and an average target price of $70.05.

Get Our Latest Analysis on Centene

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.